Latest Stock Split Details
Key information about Tasly Pharmaceutical Group Co., Ltd's most recent stock split
Split Date: 2018-06-05
Split Ratio: 7:5
Price Before Split: $40.61
Price After Split: $29.01
Developer API
Get 600535.SS split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/600535.SS
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.40 times more shares (a 7:5 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Tasly Pharmaceutical Group Co., Ltd's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2018-06-05 | 7:5 | No | $40.61 | $29.01 |
| 2013-05-22 | 2:1 | No | $80.39 | $40.19 |
| 2007-05-30 | 8:5 | No | $36.29 | $22.68 |
| 2005-12-30 | 129:100 | No | $12.71 | $9.86 |
| 2003-06-03 | 3:2 | No | $19.50 | $13.00 |
About Tasly Pharmaceutical Group Co., Ltd
Company overview and industry information
Tasly Pharmaceutical Group Co., Ltd (600535.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 7-for-5 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Tasly Pharmaceutical Group Co., Ltd Summary